Earlier this month, the American Psychiatric Association decided to remove
Gender Identity Disorder (GID) from the latest version of the Diagnostic and Statistical Manual’s (DSM) list of mental disorders. GID was defined as a condition in which the person experiences dissatisfaction with the sex they were assigned at birth and with the gender stereotypes associated with that sex, often leading to dysphoria, or intense feelings of discontent.
This is welcome news, since GID is being replaced by the term “Gender Dysphoria,” which is less pathologizing since it does not signify a mental disorder or that something is “wrong” with the person who identifies as a trans man or a trans woman. Instead, the focus is placed on the distress experienced by the person undergoing the transition.
Last week the Endocrine Society announced new treatment guidelines for transgender teenagers. The country’s oldest endocrinology organization recommended that transgender youth be given hormone blockers to delay the onset of the physical changes that result from puberty, and that hormone therapy should only be given to teenagers after the age of 16 so that teens can be absolutely sure that they are transgender. According to the